NEIMETH stock price and financial data
Invest with RicherFin and research the stock. NEIMETH (NEIMETH), NGX : share price and history, results and fundamentals, analysis tools and peer companies.
An investment account is required to buy shares. Demo mode uses virtual money: no order is sent to the market.
Price history
Issuer profile
Neimeth International Pharmaceuticals Plc is a Nigeria-based company, which is engaged in the manufacturing and marketing of pharmaceuticals and animal health products. The Company operates through two segments: Pharmaceuticals product group and Animal health product group. Pharmaceuticals product group is engaged in the marketing and sales of the Company's branded products and the products under the consumer product group. Animal health product group is engaged in the marketing and sales of poultry and animal range of anthelmintics, as well as production medicaments. Its products include Ethical Products, Veterinary Products, and Healthcare Products. Its Ethical Products include Ciklavit, Flucosyd, Amlovar, Norduet, and Normoretic, among others. Veterinary Products include Neimeth Piperazine, Neimycin Chick powder, and Neiva Stress. Its Healthcare Products include Antimal, Homtamin G, Urah, and Pancemol, among others. The Company operates in two geographic regions: Nigeria and Ghana.
Fundamentals
connect to view moreSign in to unlock the full fundamentals history.
Sign in| Metric (NGN, B) | 2024 2024 | 2023 2023 | 2022 2022 | 2021 2021 | 2020 2020 |
|---|---|---|---|---|---|
| Revenue Total Revenue | 4.49 | ||||
| EBITDA | 1.96 | ||||
| EBIT | 1.83 | ||||
| Net income Net Income | -0.89 | ||||
| Net margin | -19.74% |